Longitudinal clinical manifestations of Fanconi anemia: A systematized review

Blood Rev. 2024 Nov:68:101225. doi: 10.1016/j.blre.2024.101225. Epub 2024 Aug 2.

Abstract

Fanconi anemia (FA) is a rare and complex inherited genetic disorder characterized by impaired DNA repair mechanisms leading to genomic instability. Individuals with FA have increased susceptibility to congenital anomalies, progressive bone marrow failure, leukemia and malignant tumors, endocrinopathies and other medical issues. In recent decades, steadily improved approaches to hematopoietic cell transplantation (HCT), the only proven curative therapy for the hematologic manifestations of FA, have significantly increased the life expectancy of affected individuals, illuminating the need to understand the long-term consequences and multi-organ ramifications. Utilizing a systematized review approach with narrative synthesis of each primary issue and organ system, we shed light on the challenges and opportunities for optimizing the care and quality of life for individuals with FA and identify knowledge gaps informing future research directions.

Keywords: Fanconi anemia; Late effects; Long-term; Outcomes.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Disease Management
  • Disease Progression
  • Fanconi Anemia* / diagnosis
  • Fanconi Anemia* / genetics
  • Fanconi Anemia* / therapy
  • Hematopoietic Stem Cell Transplantation / adverse effects
  • Humans
  • Quality of Life